banner

Investors

At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

09/02/20
SAN DIEGO --(BUSINESS WIRE)--Sep. 2, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate at the following upcoming virtual investor conferences: Citi 15th Annual BioPharma Virtual Conference Date: Wednesday, September 9, 2020 Panel: Emerging Therapies for
08/31/20
SAN DIEGO --(BUSINESS WIRE)--Aug. 31, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Dr. Gudarz Davar as Executive Vice President and Head of Research and Development. Dr. Davar will be responsible for leading research and development activities at ACADIA and
08/25/20
- First-in-class, non-opioid, mechanism interrupts pain pathways - Phase 2 initiation planned for the first half of 2021 SAN DIEGO & FORT WORTH, Texas --(BUSINESS WIRE)--Aug. 25, 2020-- ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the acquisition of CerSci Therapeutics, a